Xarelto Lawsuits

Xarelto is a popular blood thinner that has caused irreversible internal bleeding in some people taking it. This bleeding has led to other serious complications, such as brain damage. In the most severe cases, people have died from taking Xarelto.

Many consumers and their families are taking legal action against the manufacturers of Xarelto. Lawsuits can help recover the costs of medical bills, lost wages and emotional distress. These lawsuits are a means of holding drug manufacturers accountable for their product and providing compensation to their victims.

People are filing personal injury and wrongful death claims against Xarelto’s manufacturers. Many of these cases have moved to multidistrict litigation (MDL).

You may be eligible to file a lawsuit if you believe Xarelto caused any of the following:

• Internal bleeding
• Pulmonary embolism
• Heart attack
• Stroke
• Brain hemorrhage
• Death

Xarelto is a product of Bayer and Johnson & Johnson. Janssen Pharmaceuticals, Inc., a subsidiary of J&J, developed the drug. These manufacturers are being held responsible for the complications caused by Xarelto.

These companies spent millions to promote Xarelto when they began selling it in 2011. Despite the trauma Xarelto caused, sales of the drug continue to mount into the billions of dollars.

Legal Complaints Against Xarelto

People are suing Bayer and Johnson and Johnson (J&J) for failing to fully inform consumers about Xarelto’s risks. In Xarelto lawsuits, plaintiffs claim they weren’t aware the drug could cause irreversible bleeding.

Plaintiffs also say the manufacturers didn’t explain that there is no antidote for Xarelto. This drug can thin the blood to the point where it leaks from blood vessels inside the body.

Because there is no medical solution for bleeding caused by Xarelto, patients have to wait until the drug leaves their system before the bleeding stops. This has led to severe complications in some cases. Uncontrolled internal bleeding can cause cardiac arrest, respiratory failure and death.

Several studies point to the risks of Xarelto in people with kidney problems. Namely, people with kidney disease are more likely to have uncontrollable bleeding while taking Xarelto. Despite these risks, the instances of those people taking the drug has risen.

Doubts About Xarelto

By 2012, the Food and Drug Administration (FDA) had approved Xarelto to treat several conditions. Approved uses of Xarelto include treatment for: atrial fibrillation (AF), deep vein thrombosis (DVT) and pulmonary embolism (PE).

Some reports have brought up concerns about how researchers conducted clinical trials of Xarelto for AF. In its first major trial, Xarelto was compared with warfarin, a blood thinner used for decades. Some reports suggest the results of these trials may be skewed, because doctors offered lower quality treatment with warfarin than with Xarelto.

FDA reviewers said Xarelto warrants “the need for additional data to support approval.” The FDA’s advisory committee has frequently advised against the use of Xarelto for conditions such as acute coronary syndrome.